Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of malignant CD19+/CD5+ B cells in blood, bone marrow, and lymphoid organs [1–3]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.